 All patients will receive lymphodepleting chemotherapy with fludarabine 30 mgm2d intravenously iv on days -5,-4,-3 and -2 cyclophosphamide 500 mgm2d iv on day -3,-2 before CAR T cell transfer to enhance the in vivo expansion of CAR T cells. 